[Results of parenteral treatment in sideropenic anemia using iron dextran (Fedex)]. 1975

R Ruvidić

UI MeSH Term Description Entries
D007505 Iron-Dextran Complex A complex of ferric oxyhydroxide with dextrans of 5000 to 7000 daltons in a viscous solution containing 50 mg/ml of iron. It is supplied as a parenteral preparation and is used as a hematinic. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1292) Dextran-Iron Complex,Dexferrum,Dextrofer,Feosol,Ferridextran,Hematran,Icar,Imfergen,Imferon,Imperon,Imposil,InFed,Norferan,Dextran Iron Complex,Iron Dextran Complex
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000747 Anemia, Hypochromic Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393) Chlorosis,Anemias, Hypochromic,Chloroses,Hypochromic Anemia,Hypochromic Anemias

Related Publications

R Ruvidić
March 1960, The Illinois medical journal,
R Ruvidić
December 1978, Voprosy okhrany materinstva i detstva,
R Ruvidić
November 1957, Nederlands tijdschrift voor geneeskunde,
R Ruvidić
February 1990, DICP : the annals of pharmacotherapy,
R Ruvidić
November 1979, Journal of the National Medical Association,
R Ruvidić
June 1957, Journal of the American Medical Association,
Copied contents to your clipboard!